Advanced search
Publication Cover
Journal of Pharmaceutical Policy and Practice Volume 13, 2020 - Issue 1
Submit an article Journal homepage
41
Views
0
CrossRef citations to date
0
Altmetric
Research

Compliance with the north American Society of Pacing and Electrophysiology guidelines on amiodarone monitoring in Riyadh, Saudi Arabia: a retrospective charts review study

Bander Ahmed Albassam1 College of Pharmacy,King Saud bin Abdulaziz University for Health Sciences,Riyadh,Saudi Arabia.;2 King Abdullah International Medical Research Center,Riyadh,Saudi Arabia.
,
Nouf Mohammed Almutairi1 College of Pharmacy,King Saud bin Abdulaziz University for Health Sciences,Riyadh,Saudi Arabia.;2 King Abdullah International Medical Research Center,Riyadh,Saudi Arabia.
,
Sarah Fahad Aldosari1 College of Pharmacy,King Saud bin Abdulaziz University for Health Sciences,Riyadh,Saudi Arabia.;2 King Abdullah International Medical Research Center,Riyadh,Saudi Arabia.
&
Hind Saleh Almodaimegh1 College of Pharmacy,King Saud bin Abdulaziz University for Health Sciences,Riyadh,Saudi Arabia.;2 King Abdullah International Medical Research Center,Riyadh,Saudi Arabia.;3 Pharmacutical Care Services,King Abdualziz Medical City,Riyadh,Saudi Arabia.Correspondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7620-6054
ORCID Icon
Article: 37 | Received 04 Dec 2019, Accepted 31 May 2020, Published online: 04 Dec 2023

References

  • Khan MH. Oral class III antiarrhythmics: what is new? Curr Opinion Cardiol. 2004;19(1):47–51.
  • Kochiadakis GE Igoumenidis NE, Hamilos MI, Tzerakis PG, Klapsinos NC, Zacharis EA, et al. Long-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation: amiodarone vs propafenone, both in low doses. Chest. 2004;125(2):377–383.
  • Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian trial of atrial fibrillation investigators. N Engl J Med. 2000;342(13):913–920.
  • Goldschlager N, Epstein AE, Naccarelli GV, Olshansky B, Singh B, Collard HR, et al. A practical guide for clinicians who treat patients with amiodarone: 2007. Heart Rhythm. 2007;4(9):1250–1259.
  • Epstein AE, Olshansky B, Naccarelli GV, Kennedy JIJr, Murphy EJ, Goldschlager N. Practical management guide for clinicians who treat patients with Amiodarone. Am J Emerg Med. 2016;129(5):468–475.
  • Bickford CL, Spencer AP. Adherence to the NASPE guideline for amiodarone monitoring at a medical university. J Manag Care Pharm. 2006;12(3):254–259.
  • Burgess C, Blaikie A, Ingham T, Robinson G, Narasimhan S. Monitoring the use of amiodarone: compliance with guidelines. Intern Med J. 2006;36(5):289–293.
  • Lavon O, Goldman R. Adherence to monitoring guidelines of Amiodarone adverse reactions. Health Serv Res Manag Epidemiol. 2019;6:1–4
  • Rankin S, Elder DH, Ogston S, George J, Lang CC, Choy AM. Population-level incidence and monitoring of adverse drug reactions with long-term amiodarone therapy. Cardiovasc Ther. 2017;35(3):e12258.
  • Huang CJ, Tseng CL, Chu CH, Huang DF, Huang CC, Lin LY. Adherence to guidelines in monitoring amiodarone-induced thyroid dysfunction. J Eval Clin Pract. 2017;23(1):108–113.
  • Johnson SG, Canty K, Billups S, Schimmer J. Adherence to amiodarone monitoring recommendations before and after implementation of a centralized pharmacy service: a cohort study. J Pharm Pract. 2010;23(6):536–539.
  • Raebel MA, Lyons EE, Chester EA, Bodily MA, Kelleher JA, Long CL, et al. Improving laboratory monitoring at initiation of drug therapy in ambulatory care: a randomized trial. Arch Intern Med. 2005;165(20):2395–2401.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.